Browsing Tag
The Christie NHS Foundation Trust
1 post
Poolbeg Pharma (AIM: POLB) raises ÂŁ3.5m to fund POLB 001 and oral GLP-1 trials
The discounted placing should fund two potentially value-defining clinical studies through completion, although investors must absorb a larger share base before either programme produces proof-of-concept data.